BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
137 results:

  • 1. Hyaluronic acid-based injectable formulation developed to mitigate metastasis and radiation-induced skin fibrosis in breast cancer treatment.
    Wang YC; Shueng PW; Hu CY; Tung FI; Chen MH; Liu TY
    Carbohydr Polym; 2024 Jul; 336():122136. PubMed ID: 38670762
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Use of schisandrin B to Combat Triple-Negative breast cancers by Inhibiting NLRP3-Induced Interleukin-1β Production.
    Chang CM; Liang TR; Lam HYP
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254674
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings.
    Fnaiche A; Mélin L; Suárez NG; Paquin A; Vu V; Li F; Allali-Hassani A; Bolotokova A; Allemand F; Gelin M; Cotelle P; Woo S; LaPlante SR; Barsyte-Lovejoy D; Santhakumar V; Vedadi M; Guichou JF; Annabi B; Gagnon A
    Bioorg Med Chem Lett; 2023 Oct; 95():129488. PubMed ID: 37770003
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series.
    Stenman A; Falhammar H; Zedenius J; Juhlin CC
    Endocrine; 2023 Dec; 82(3):631-637. PubMed ID: 37535242
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Neutrophil extracellular traps mediate TLR9/merlin axis to resist ferroptosis and promote triple negative breast cancer progression.
    Yao L; Sheng X; Dong X; Zhou W; Li Y; Ma X; Song Y; Dai H; Du Y
    Apoptosis; 2023 Oct; 28(9-10):1484-1495. PubMed ID: 37368176
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer.
    Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW
    BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis.
    Cômes PC; Le Van T; Tran S; Huard S; Abi-Jaoude S; Venot Q; Marijon P; Boetto J; Blouin A; Bielle F; Ducos Y; Teranishi Y; Kalamarides M; Peyre M
    Cancer Gene Ther; 2023 Aug; 30(8):1114-1123. PubMed ID: 37188724
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study.
    Chen J; Jin L; Chen L; Bian Z; Li Z; Cao S; Zhou J; Xu L; Zhao W; Wang Q
    Cancer Treat Res Commun; 2023; 36():100719. PubMed ID: 37187018
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism.
    He XY; Fan X; Qu L; Wang X; Jiang L; Sang LJ; Shi CY; Lin S; Yang JC; Yang ZZ; Lei K; Li JH; Ju HQ; Yan Q; Liu J; Wang F; Shao J; Xiong Y; Wang W; Lin A
    Nat Commun; 2023 Apr; 14(1):2253. PubMed ID: 37080959
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The anti-cancer effect of resveratrol nano-encapsulated supplements against breast cancer via the regulation of oxidative stress.
    Sajadimajd S; Aghaz F; Khazaei M; Raygani AV
    J Microencapsul; 2023 Dec; 40(5):318-329. PubMed ID: 37017511
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dark Sweet Cherry (
    Silveira Rabelo AC; Mertens-Talcott SU; Chew BP; Noratto G
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364072
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Landscape of Artificial Intelligence in breast cancer (2000-2021): A Bibliometric Analysis.
    Zhang Y; Yu C; Zhao F; Xu H; Zhu C; Li Y
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):224. PubMed ID: 36042161
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted Intervention of nf2-YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC.
    Hou L; Pu L; Chen Y; Bai Y; Zhou Y; Chen M; Wang S; Lv Y; Ma C; Cheng P; Zhang K; Liang Q; Deng S; Wang D
    ACS Nano; 2022 Apr; 16(4):5807-5819. PubMed ID: 35420780
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis.
    Shi Y; Men J; Sun H; Tan J
    Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with merlin for binding to Amot-p80.
    Tian Q; Gao H; Zhou Y; Zhu L; Yang J; Wang B; Liu P; Yang J
    Cell Death Dis; 2022 Jan; 13(1):71. PubMed ID: 35064101
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The health benefits of anthocyanins: an umbrella review of systematic reviews and meta-analyses of observational studies and controlled clinical trials.
    Sandoval-Ramírez BA; Catalán Ú; Llauradó E; Valls RM; Salamanca P; Rubió L; Yuste S; Solà R
    Nutr Rev; 2022 May; 80(6):1515-1530. PubMed ID: 34725704
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The BRCA1/BARD1 ubiquitin ligase and its substrates.
    Witus SR; Stewart MD; Klevit RE
    Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. breast Shwannoma - Time to explore alternative management strategy?
    Ashoor A; Lissidini G; Girardi A; Mirza M; Baig MS
    Ann Diagn Pathol; 2021 Oct; 54():151773. PubMed ID: 34273600
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With breast cancer or Ovarian cancer, 2012-2019.
    Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
    J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammation.
    Ma Z; Xu G; Shen Y; Hu S; Lin X; Zhou J; Zhao W; Liu J; Wang J; Guo J
    Pharmacol Res; 2021 Apr; 166():105459. PubMed ID: 33545313
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.